The structural and regulatory functions encoding tetracycline resistance in transposon TnlO lie within a 2,700-base pair region. Using recombinant plasmids with different deoxyribonucleic acid sequences adjacent to a HincII site in this region, we located the promoter controlling the expression of tetracycline resistance. These various sequences conferred altered levels of tetracycline resistance. Plasmids containing deletions of a 695-base pair HinclI fragment were constitutive and showed the loss of a 23,000-dalton tetracycline-inducible polypeptide, thus identifying the repressor and the location of its gene.
TnlO is a 9,300-base pair transposon that encodes resistance to tetracycline (16) . The mechanism of resistance involves an active efflux system which transports tetracycline out of the cell (20) . In addition, resistant cells contain an intracellular component that antagonizes the ability of tetracycline to inhibit translation (19, 44) .
The expression of tetracycline resistance is inducible by subinhibitory levels of the antibiotic (13, 14) . Three different tetracycline-inducible polypeptides with molecular weights of 36 ,000, 25,000, and 15,000 have been reported (14, 44, 46) . The largest has been called the TET protein and is regulated by a repressor which is inactive in the presence of tetracycline (44) . Analysis of the tetracycline resistance phenotypes and TET protein-coding properties of various TnlO deletions allowed the localization of the TET protein gene to the 1,275-base pair HincII fragment pictured in Fig. 1 (14) . In addition, these studies hypothesized that the promoter for the TET protein was located at or near the HincII site on the left side of this fragment (see Fig. 1 ) and that the repressor gene was located on the adjacent 695-base pair HincII fragment. The experiments described in this communication verify these hypotheses, and in addition, they identify the TET repressor protein and show that it is autoregulated.
MATERIALS AND METHODS
Bacterial strains and plasmids. Escherichia coli strain JD600 is thr leu hsdR hsdM tonA supE lacY thi. DS410 is a minicell-producing strain of E. coli that is minA minB ara lacY rpsL malA xyl azi tonA mtl thi. Plasmids pRT29 and pRZ112 have been described previously (14, 15) . Plasmid pRT86 was obtained from N. Panayotatos.
DNA preparation and restriction enzyme digestion. Plasmid DNA was prepared by the method of Humphreys et al. (12) . Enzymatic digestion of DNA with the restriction endonucleases AluI, DdeI, HhaI, Hinfl, RsaI, Sau3AI, Sau96I, HincII, EcoRI, and XbaI was performed in 60 mM NaCl-7 mM MgSO4-10 mM Tris-hydrochloride (pH 7.9). Endonucleolytic digestion of DNA with the enzymes FnuDII, HaeII, HaeIII, and TaqI was performed in 6 mM MgCl2-0.5 mM dithiothreitol-10 mM Tris-hydrochloride (pH 7.9). Li (21) . The cells were inoculated into 4 ml of L-broth (27) (18) , and 40 jil was loaded on 10 to 15% gradient polyacrylamide-sodium dodecyl sulfate slab gels (18) . Electrophoresis was at 40 mA for 2 to 3 h, using a constant-current power supply. The gel was stained with Coomassie blue, destained, and then treated with the fluor EN;3HANCE (New England Nuclear Corp.). Gels were dried by heating under vacuum at 55°C, and fluorographs were prepared at -70°C, using Kodak XOmat R film. Molecular-weight standards (Dalton Mark VI, Sigma Chemical Co.) were electrophoresed in a lane adjacent to the minicell samples, and the mobility of the stained standards in the gel was compared with that of the labeled bands on the fluorograph.
RESULTS
Construction and characterization of pRT86 mutants. In an earlier communication (14) the regulatory elements controlling tetracycline resistance were mapped in TnlO HpaI fragment 2025. HincIl fragment 695 was suggested to be the location of the tet repressor gene. Plasmid pRT86 is a derivative of pRT29 that contains a deletion at the HpaI restriction site (see Fig. 1 ). Plasmid pRT86 was selected for study because it contains only two HincIl sites; this allowed for easy in vitro construction of deletion and substitution mutants of the control region.
The structures of the TnlO-related portion of these plasmids are shown in Fig. 1 . In plasmid pRT201, the sequence between the HinclI and XbaI sites has been deleted, whereas pRT202 contains a deletion of the entire HinclI fragment 695. The three plasmids pRT203, pRT204, and pRT205 contain substitutions in which the HincIl fragment 695 has been replaced with a 789-base pair fragment containing the lac promoter region. The HincIL sites were regenerated at both ends in pRT203 and pRT204, but only at one end in pRT205 (Fig. 2) Both plasmids pRT29 and pRT86 encode an inducible resistance phenotype, although they confer resistance to different levels of tetracycline. This is consistent with the previous report (14) that derivatives of pRT29 which contain insertions at the HpaI site also have altered levels of tetracycline resistance.
Plasmid pRT201 confers a constitutive tetracycline resistance phenotype. This level of resistance is higher than that observed for induced cells carrying pRT86. This phenomenon has been observed with other constitutive tetracycline resistance mutants (31) . The constitutive phenotype of this mutant suggests that the deletion in pRT201 has removed either the sequence coding for the repressor or the control site regulating the expression of resistance or both.
Plasmids pRT202, pRT203, pRT204, and pRT205 also display a constitutive resistance phenotype, but the level of resistance is different for each plasmid. These mutants all differ with respect to the DNA sequences adjacent to the HincII site of the left side of the 1,275-base pair fragment. An earlier study (14) has shown that this HincIl site is incompletely digested in the presence of RNA polymerase and is thought to lie within the tet promoter. Thus, it appears that these mutants contain an altered tet promoter and that the different tetracycline resistance levels are the consequence of promoters with altered levels of expression.
Effect of mutants on plasmid-encoded protein synthesis. The synthesis of polypeptides encoded by plasmids can be studied through the use of minicell-producing E. coli strains. Plasmids pRT29 and pRT86 code for tetracycline-inducible polypeptides with molecular weights of 37,000 and 34,000, respectively (37K and 34K proteins; Fig. 3A) . The deletion which generated pRT86 removes a DNA sequence from the region identified as coding for the carboxy terminus of the TET protein (14) . The 37K and 34K proteins are fusion polypeptides of the 36K TET protein that are the result of these different deletions in the carboxyl end of the TET protein-coding region. Both plasmids direct the synthesis of a 23,000-dalton polypeptide (23K polypeptide). Qualitatively, it appears that this polypeptide is tetracycline inducible.
Plasmids pRT201, pRT203, and pRT204 all code for a constitutive 34K polypeptide (Fig. 3A  and B ). In addition, the 23K polypeptide is not present. From this observation it appears that the 23K polypeptide may function as the tet repressor and be encoded in the 695-base pair HincII fragment. Plasmids missing this fragment do not direct the synthesis of the 23K polypeptide and result in the constitutive expression of the resistance function.
Plasmids pRT202 and pRT205 do not direct the synthesis of the 23K polypeptide (Fig. 3A  and B) . Moreover, they produce no detectable amount of the 34K TET fusion protein. This is consistent with the idea that the low level of tetracycline resistance conferred by these plasmids results from promoters with lowered levels of expression.
Recombinant plasmids pRT210 and pRT211 contain HincII fragment 695 inserted in opposite orientations. The inserts are directly adjacent to the Tn5 left inverted repeat promoter (34) . pRT211 codes for a constitutive 23K polypeptide, whereas this protein is not synthesized by pRT210. From this observation, we can conclude that the 695-base pair HincII fragment does not contain the promoter controlling the expression of the 23K polypeptide. In addition, the direction of transcription is from right to left, as the map is drawn in Fig. 1 .
Restriction enzyme mapping of DNA fragments containing the tet control region. The restriction map of the control region was determined by making use of the XbaI restriction site. This enzyme cleaves pRT86 at only one site, and this site is directly adjacent to the tet promoter (see Fig. 1 ). For a given restriction enzyme, the DNA fragment containing the control region was identified by comparing the gel patterns of digestions of pRT86 with and without XbaI. Since there is a HinclI cleavage site located about 30 base pairs from the XbaI site, the orientation of the two fragments produced by Xbal cleavage was determined by comparing the XbaI double digest with a HincIl double digest. The results for 11 different restriction enzymes are summarized in Fig. 4 .
DISCUSSION
The promoter controlling the expression of tetracycline resistance in TnlO has been identified by placing different DNA sequences on the upstream side of the RNA polymerase-protected HinclI site. These mutations conferred altered levels of tetracycline resistance and directed the synthesis of altered levels of the resistance protein. E. coli promoter sites are known to contain areas of sequence homology known as the Pribnow or Schaller box (29, 30, 36 ) and the -35 or recognition region (38, 42) . Several promoters are known to contain HinclI cleavage sites within the recognition region, e.g., the trp operon promoter (2), the bacteriophage X Pi, and pR promoters (22, 24, 43) , the bacteriophage pX174 D promoter (35) , and the rRNA promoters D2, E2, and X2 (6, 45) . Point mutations which alter promoter activity have been localized in the recognition region for a number of different promoters, e.g., the bacteriophage X pi,, PRM, and PIE promoters (17, 26, 27) , the lacI gene promoter (4) , and the lac operon promoter (7, 32) . In addition, Rodriguez et al. (33) have reported that the insertion of DNA into the recognition region of the tetracycline resistance gene promoter in pBR313 alters the level of tetracycline resistance. Thus, it seems plausible that the RNA polymerase-protected HinclI site in TnlO lies within the recognition region of the TET gene promoter and that the insertion of DNA at this site could alter promoter activity.
The tetracycline resistance repressor is a polypeptide with an apparent molecular weight of 23,000 and is most likely identical to the 25K tetracycline-inducible polypeptide identified by Zupancic et al. (46) . The observation that it is tetracycline inducible suggests that the repressor regulates its own synthesis. Other repressor molecules have been demonstrated or suggested to be autogenously regulated, e.g., the bacteriophage X repressor (26) , the lexA protein (3), the Tn3 transposase repressor (5) , and the trp operon repressor (40) . The repressor gene is located within HinclI fragment 695 and is transcribed in a direction that is opposite that of the tetracycline resistance gene. The possibility that the transcription of these genes originates from a common control region is suggested by the observation that the 695-base pair HincIl fragment does not contain the promoter controlling repressor synthesis. Such divergently transcribed control regions have been described for bacteriophage X (22, 26, 43) , transposon Tn3 (10), and biosynthetic gene clusters argECBH (8) and bioABFCD (9) .
In Fig. 5 we present a simple model for the location and organization of the tet resistance gene and its repressor on Tnl 0. The presentation of two operators is arbitrary and is based on the observation that uninduced minicells produce repressor but do not produce resistance protein (Fig. 3) . This suggests that the two genes have different regulatory sites.
In a subsequent communication (K. P. Bertrand, L. V. Wray, Jr., and W. S. Reznikoff, manuscript in preparation), we shall describe the construction and use of X phages in which the TET protein promoter and the tet repressor promoter have each been fused to the lacZ gene.
The properties of these fusions have confirmed the localization and regulatory properties of the two promoters and the repressor described in this communication. 
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